The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme
- Citation:
- Neuro-oncol vol 9 (1) 29-38
- Year:
- 2007
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Book Volume:
- Parents:
- 559
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Karla V. Ballman Jan C. Buckner Paul D. Brown Caterina Giannini Patrick J. Flynn Betsy R. LaPlant Kurt A. Jaeckle
- Networks:
- Study
- NCCTG-N047D
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- N/A
- Keywords:
- end points, glioblastoma multiforme, phase II clinical trials